Fate of lymphocytes after withdrawal of tofacitinib treatment. PLoS One 2014;9(1):e85463.
. Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease. World J Gastroenterol 2015;21(14):4379-84.
. Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes. Int Immunopharmacol 2011;11(12):2242-5.
. Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage. Nutrients 2017;9(6)
. Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis. Blood Cells Mol Dis 2016;59:97-9.
. Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds. Int J Mol Sci 2014;15(4):6843-56.
. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. Clin Immunol 2015;159(1):33-6.
. Alendronate, a double-edged sword acting in the mevalonate pathway. Mol Med Rep 2015;12(3):4238-42.
. Action of methotrexate and tofacitinib on directly stimulated and bystander-activated lymphocytes. Mol Med Rep 2016;14(1):574-82.
.